Summary: Antibodies were raised against seven major matrix metalloproteinases: stromelysin-1 (MMP-3), stromelysin-2 (MMP-10), stromelysin-3 (MMP-11), interstitial collagenase (MMP-1), M. 72 000 type IV collagenase (72 kDa type IV collagenase, MMP-2), M T 92 000 type IV collagenase (92 kDa type IV collagenase, MMP-9) and matrilysin (PUMP, MMP-7) as well as against prolyl 4-hydroxylase, to study the expression of these collagenolytic enzymes in normal liver in relation to the activity of collagen synthesis. Tissue samples of four normal human livers, three hepatocellular carcinomas and one cholangiocellular carcinoma were analysed. In normal liver we found expression of stromelysin-1, stromelysin-3, interstitial collagenase, M T 72 000 and M r 92 000 type IV collagenases and varying expression of prolyl 4-hydroxylase. Stromelysin-2 was inconsistently detectable; matrilysin was not found. In hepatocellular carcinoma the expression pattern of matrix metalloproteinases showed only minor changes compared with the normal tissue; stronger signals than in normal tissue were seen for stromelysin-1, and stromelysin-2 was also strongly positive.
Introduction
breakdown and matrix turnover in normal and diseased liver is still poorly understood. The normal liver matrix contains about 4-6 mg collagen per gram liver tissue. In fibrotic diseases the colla-Circumstantial evidence suggests that in normal liver gen content is significantly increased, reaching as much collagen synthesis and turnover are balanced, keeping as 30% of the total liver weight (1) . Extracellular matrix the collagen content fairly stable (4) . In chronic diseases consists of different collagens, of which collagen type this balance might be tilted towards an increasing predo-I is the most abundant, comprising up to 70% of the minance of fibrogenesis, resulting in an accumulation of extracellular matrix in fibrotic liver.
collagenous matrix and finally organ fibrosis and cirrhosis. While considerable progress has been made concerning the cellular source of matrix proteins (collagens, glycos-Collagen turnover is largely the effect of matrix metalloaminoglycans and glycoproteins) and the regulation of proteinases, a family of neutral proteinases requiring their expression (2, 3), the amount and rate of collagen zinc ions for activity and digesting different collagens Lichtinghagcn et al.: Matrix metalloproteinases in human liver and gelatins (denatured collagen derivatives) (5, 6) . Their activity is regulated both on the transcriptional level, by proenzyme activation and finally by inhibitors which are coexpressed and are present at the tissue sites of enzyme activity (7) . Earlier reports suggest that hepatic perisinusoidal (Ito-) cells, besides producing different collagens are also capable of expressing matrix metalloproteinases (8) (9) (10) . High levels of collagenase activity have been found in alcoholic liver disease with active fibrogenesis and after carbon tetrachloride poisoning in the rat. It is not known however, which of the numerous collagenases were responsible for this effect (11, 12) .
Other investigators found M r 72 000 type IV collagenase (MMP-2) transcripts in normal and both interstitial collagenase (MMP-1) and M r 72000 type IV collagenase transcripts in fibrotic human liver (13) . Very little is known about the expression of other matrix metalloproteinases or their inhibitors in the human liver in vivo (14) .
In the study presented here, we investigated the expression of seven major matrix metalloproteinases and of prolyl 4-hydroxylase, the rate limiting enzyme of posttranslational modification of collagen, in normal human liver and in hepatocellular as well as cholangiocellular tumour tissue. The aim of the study was to establish laboratory methods for further studies of metalloproteinase expression and to determine which metalloproteinase repertoire is found in normal liver.
Materials and Methods
Production of specific antisera against different matrix metalloproteinases and prolyl 4-hydroxylase Fragments of cDNA, coding for parts of the haemopexin-like domain (15) The denaturing temperature was 94 °C, annealing temperatures were 54-59 °C. Thirty-five cycles at 72 °C were run using first strand cDNA matrices (0.2 μg) derived from human breast carcinoma (for stromelysin-1,-2,-3) or a liver metastasis of a colon carcinoma (for matrilysin, M r 72 000 and M r 92 000 type IV collagenases, interstitial collagenase and prolyl 4-hydroxylase), respectively. For cloning purposes, BamHl recognition sites were included in the sense and EcoRl recognition sites in the antisense primers. After amplification, DNA fragments (27) were digested with restriction enzymes BamHl 1 ) and EcoRl 1 ) and then ligated with BamHl/EcoRl cut pGEX-2T-DNA yielding STR1-, STR2-, STR3-, PU-, 1C-, 72KD-, 92KD-and PH-pGEX expression clones, respectively. Sequences were similary cloned into the expression vector pET-2la(+) using DNA fragments amplified by PCR with primer pairs as above except that EcoRl recognition sites were substituted by HindllV) sites. When using the pUR-288 expression vector, EcoRl sites were substituted by Xbal 1 ) sites. Clones were checked by sequencing (28) .
Expression of the fusion proteins was induced with 0.5 mrnol/l isopropyl -D-thiogalacto-pyranoside for pGEX (yielding a fusion protein with M T 27 500 glutathione S-transferase at the amino-terEur J Clin Chem Clin Biochem 1995; 33 (No 2) minus), pET-21a(+) constructs (giving a fusion protein with a 18 amino acids peptide, including a histidine-tag, at the carboxy-terminus) and pUR-288 (amino-terminal fusion with M T 116000 of -galactosidase). Cells were lysed by sonication three hours after induction and centrifuged at 10000g. The pellets were resuspended in SDS sample buffer and subjected to preparative SDS polyacrylamide gel electrophoresis; bands containing the induced fusion proteins were excised and electroeluted using a Biotrap apparatus (Schleicher & Sch ll, Germany). Purity of the recovered proteins was assayed by analytical SDS polyacrylamide gel electrophoresis. Protein concentrations were determined colorimetrically with coomassie brilliant blue staining (29) . The pGEX fusion proteins were used to immunize 4-to 5-month old Chinchilla rabbits following standard protocols (30) . Specificities of the antisera were determined by enzyme-linked immunosorbent-assay (ELISA) (30) using either pGEX fusion proteins after affinity chromatography on glutathione-sepharose columns (Pharmacia) and thrombin-cleavage (STR1, STR2) (16), pET constructs (STR3, PU, 1C and PH) or pUR fusion proteins (72 KD and 92 KD) as antigens to avoid cross reactivities from the glutathione S-transferase part of the fusion protein.
Sera were stored in aliquots at -20 °C until used. An additional construct (STROM-pGEX) encompassing an amino-terminal portion of stromelysin-1 (STROM: nucleotides 227-646, amino acids 72-210) was prepared like STRl-pGEX for characterizing specific antibodies against PUMP.
Enzyme-linked immunosorbent-assay (ELISA) (30) Microtitre plates were coated overnight with 100 μΐ of the antigen (1 mg/1) diluted in coating buffer (106 g/1 Na 2 CO 3 , 336 g/1 NaHCOs) and then blocked for 30 min in an additional 150 μΐ blocking buffer (50 mmol/I NaH 2 PO 4 , 150 mmol/1 NaCI, 0.5 g/1 Tween 20, 0.2 g/1 NaN 3 , 1 g/1 haemoglobin; pH 7.2). The plates were washed three times with 200 μΐ washing buffer (blocking buffer without haemoglobin). Hundred μΐ of crude antisera diluted in blocking buffer were incubated for two hours (dilutions are indicated in the legend to fig. 1 ) then washed three times with 200 μΐ phosphate-buffered saline before peroxidase conjugated sheep antirabbit IgG antibody (1 : 500) (Boehringer Mannheim) was added. After a 30 min incubation it was washed three times with phosphate-buffered saline. The antibody complex was visualized 10 min after addition of the chromogen di-ammonium 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonate) (ABTS) (Boehringer Mannheim) giving raise to a green colour whose intensity was measured at 405 mri.
Tissue preparation
Normal liver tissue was obtained from four explanted livers which were meant for liver transplantation but could not be utilized for reasons unrelated to this study. Tumour tissue was excised from resected neoplasms immediately in the operation theatre and placed in cold Ringer lactate solution (Baxter) on crushed ice. Three hepatocellular carcinomas and one cholangiocellular carcinoma were analysed. Pieces of approximately 100 mg were homogenized in 300 μΐ SDS sample buffer (125 mmol/1 Tris/HCl, pH 6.8, 30 g/1 sodium dodecylsulphate, 50 g/1 2-mercaptoethanol, 150 g/1 glycerol) using an ultra-turrax (Kinematica). The samples were boiled for 10 min, centrifuged at 10 000 g and the supernatant was stored at -20 °C,
Western blot analysis
The tissue extracts (1 -4 μΐ, see tissue preparation) were subjected to analytical SDS polyacrylamide gel electrophoresis (gel size: 6.0 X 8.5 cm) and then transferred to nitrocellulose strips (BA85, Schleicher & Schuell) in a Sartoblot2 transfer appartus (Sartorius). A set of prestained protein standards was simultaneously run on SDS polyacrylamide gel electrophoresis and transferred to excised strip. The blotted membrane was blocked over night with 1% blocking reagent (Boehringer Mannheim) in Tris-buffered saline (50 mmol/1 Tris base, 150 mmol/1 NaCI, pH 7.5). Subsequently, membrane strips were incubated for two hours at room temperature with the primary antiserum diluted in 5 g/1 blocking reagent in Trisbuffered saline (dilutions are indicated in the legend to fig. 2 ). Membrane, strips were washed two times in Tris-buffered saline with 1 g/1 Tween 20, two times in 5 g/1 blocking reagent in Trisbuffered saline, and incubated for a further hour with peroxidaseconjugated sheep anti-rabbit IgG (Boehringer Mannheim; 1 : 1000 in 5 g/1 blocking reagent in Tris-buffered saline). After four washing steps in Tris-buffered saline (with 1 g/1 Tween 20) immunoreactive bands were visualized using a luminol-based detection system (Boehringer Mannheim) and a i min exposure to X-OMAT AR-film (Kodak). For competition analysis, diluted primary antisera were preincubated with fusion proteins (10 mg/1) for twelve hours, prior to incubation with the membrane strip.
Cell isolation
Ten day old cultures of hepatic cell preparations were analysed. Cells were isolated by the two step collagenase method according to Seglen (31) . After isolation the entire cell-suspension, containing hepatocytes and all non-parenchymal cell fractions was cultured on collagen-coated plastic dishes in medium 199 earle (Seromed) supplemented with insulin, dexamethasone, penicillin/streptomycin and 100 g/1 fetal calf serum. Cells were seeded at a density of approximately 4 X 10 6 per 25 cm 2 dish. Medium was changed every 24 hours. Cells were harvested on day ten by removing them from the culture dish with a rubber policeman. They were washed three times with phosphate-buffered saline, centrifuged at 10 000 g, homogenized and analysed as described for tissue samples.
Results

Antibody engineering
Using published cDNA sequences of seven major matrix metalloproteinases, we selected primers and amplified cDNA sequences of these proteins from human tumour tissues by the polymerase chain reaction (see Materials and Methods). cDNA sequences were derived from parts of the haemopexin-like domain of the matrix metalloproteinase gene family. In the case of matrilysin, where this region is completely absent, we selected the propeptide and catalytic domain (15) . The cDNA sequences chosen show as little sequence homology to other members of the matrix metalloproteinase family on the protein level as possible. The amplified cDNA fragments were shown to be of the expected molecular size and were sequenced and found to be identical to the published cDNA sequences (20) (21) (22) (23) (24) (25) (26) (27) . They were cloned into bacterial expression vectors in E. coli (see Materials and Methods). Since the sequences chosen did not contain glycosylation sites, the synthesized proteins could successfully be used as antigenic substitutes in rabbits, inducing antibodies which should specifically recognize a single member of the matrix metalloproteinase family.
Specificity of the raised antisera Figure 1 shows the results of ELISA-testing of crude rabbit-antisera against their own and related recombinant antigens. Comparisons between STR1-, STR2-, STR3-, 1C-, 72 KD-and 92 KD-antigens were performed with each antisera. For testing anti-PU (anti-matrilysin) we used a recombinant stromelysin-1 (STROM) which corresponds to the homologous region of the matrilysin-antigen (see Materials and Methods). All the antisera recognized their respective recombinant antigens with sufficient specificity. Anti-STRl (anti-stromelysin-1) cross reacted with both the stromelysin-1 and the stromelysin-2 antigen, while anti-STR2 (anti-stromelysin-2) only showed a weak cross-reactivity with stromelysin-1.
Immunoblotting (western blots, see fig. 2 ) revealed that the antisera also reacted with the intact human matrix metalloproteinase proteins. The shown reference blots demonstrate that dominant bands of the appropriate molecular size were detected by the antisera in preparations derived from cultures of human liver cells, tumour tissue and serum.
Each antiserum detected a band of f the molecular size reported in the literature for the proenzyme form of the individual matrix metalloproteinase. Other bands also visible were not competitively inhibitable (data not shown), but in no case showed comparable intensities to the dominant ones.
Anti-STRl (anti-stromelysin-1) and anti-STR3 (antistromelysin-3) recognized bands comigrating with the M T 67 000 marker band, anti-IC (anti-interstitial collagenase) and anti-STR2 (anti-stromelysin-2) reacted with a band above the M r 50 000 marker band, anti-72 KD (anti-Mr 72 000 type IV collagenase) recognized a band of approximately M r 72000, and anti-92 KD (anti-M r 92000 type IV collagenase) recognized a band above the M T 89000 marker band. Anti-PU (anti-matrilysin) reacted with a band comigrating with the smallest marker band of M r 34 000; the band detected by anti-PH (anti-prolyl 4-hydroxylase) was just smaller than the M r 67 000 marker band.
Expression of matrix metalloproteinases
We used our antisera to detect matrix metalloproteinases in normal human liver and in hepatic tumours. Figure 3 shows the results of western blots done with homogenized liver or tumour tissue.
In normal human liver we found stromelysin-1 and -3, interstitial collagenase, both type IV collagenases (M r 72000 and M r 92000) and differing quantities of prolyl 4-hydroxylase. Stromelysin-2 was only inconsistently detectable and showed very weak bands, and matrilysin was not detectable. Stromelysin-1 and M r 72000 type IV collagenase seemed to be the most abundant of the matrix metalloproteinases in normal liver.
In the three hepatocellular carcinomas, the matrix metalloproteinase content seemed to be about the same as in normal tissue, although the expression level did seem to vary: most interestingly, stromelysin-2, hardly detectable in normal liver, was strongly positive in two of three hepatocellular carcinomas tested. Interstitial collagenase and both M r 72000 and 92000 type IV collagenases were less strongly detectable in the tumours. Thus stromelysins seemed to be preg lated in the tumours, while all the collagenases tested were not. ,?
Neither in normal liver nor in hepatocellular carcinoma could we detect any matrilysin protein.
Prolyl 4-hydroxylase was also more strongly positive in hepatocellular carcinoma than iri hormal liver. antisera and visualized using a luminol-based detection system. For controls antisera were blocked by preincubation with the corresponding antigens always yielding blank strips, as shown here in the case of anti-72 KD (i). Strong signals were detected with anti-92 KD using human serum from a patient with posthepatic cirrhosis as shown in (k). The antibodies always recognized bands with apparent molecular masses, which correlated well with published data. Molecular mass markers were a set of prestained proteins (prestained SDS-PAGE standard solution, (Sigma) with molecular masses of native proteins [A/ r , 10
The one cholangiocellular carcinoma tested showed an altogether different pattern of matrix metalloproteinases. Interstitial collagenase and M T 92 000 type IV collagenase were not detectable, while stromelysin-2 was less intense than in the hepatocellular carcinomas. Stromelysin-1 and stromelysin-3 showed bands of smaller size in the cholangiocellular carcinoma than in all other tissues tested. Matrilysin was only detectable in the cholangiocellular carcinoma. Prolyl 4-hydroxylase was not found.
Discussion
Many authors believe that hepatic fibrosis and cirrhosis occur in situations of a disturbed equilibrium between collagen synthesis and degradation within the liver (4, 5) . Following this hypothesis one would expect to find both collagen synthesis as well as collagen degradation in the normal liver. However, although this hypothesis is not a new one (32) little is known about the expression of collagenolytic enzymes in normal or diseased human liver.
Arthur and coworkers described synthesis and expression of type IV collagenase by rat and human lipocytes (9, 10) . This expression increased during the process of lipocyte activation, which is thought to take place also during the development of hepatic fibrosis (33) . Milani et al. demonstrated mRNA transcription for M r 72 000 type IV collagenase in both normal and diseased human liver by in situ hybridisation (13). They could not detect any mRNA for interstitial collagenase, however, and did not look for any other metalloproteinases. The main source of the mRNA detected was mesenchymal cells, thought to be perisinusoidal lipocytes.
In regenerating rat liver, Herbst et al. found increasing levels of mRNA for transin/stromelysin in both hepatocytes (maximum 24 hours) and lobular mesenchymal cells (maximum 48 hours) after carbon tetrachloride injury (34) .
In serum of patients with chronic liver diseases some investigators found increased collagenase activity, while others described profound reductions in serum collagenase activity with development of chronic active hepatitis (minus 50% compared with healthy subjects) and cirrhosis (minus 66%!) (35) .
Thus the picture is far from clear. The aim of our own study was, therefore, to describe the pattern of expression of metalloproteinases in normal human liver. Hepatic tumours were used for comparison, since we ex-Acknowledgement pected to find higher expression of matrix metalloproteinases in malignant than in normal liver cells.
Using antibodies against recombinant proteins we were able to show that stromelysin-1 and -3, interstitial collagenase, and both type IV collagenases (M r 72 000 and M T 92 000) are present in healthy human liver. We also detected weak signals for stromelysin-2 in three of the normal livers analysed. Only matrilysin was not detectable. Interestingly, with regard to the equilibrium hypothesis, we also found varying degrees of prolyl 4-hydroxylase expression in normal liver tissue, suggesting that indeed some collagen synthesis takes place.
In the hepatocellular carcinomas we saw expression of all the metalloproteiri ses tested for, except matrilysin. Stromelysin-2 was also strongly positive in two of the three hepatocellular carcinomas.
M r 72000 type IV collagenase seemed to be less strongly expressed in hepatocellular carcinoma than in normal liver. This may be in accordance with the finding by Murawaki (35) who described reduced levels of collagenase activity in the serum of patients with hepatocellular carcinoma. In the only cholangiocellular carcinoma analysed, there was a completely different pattern of metalloproteinase expression. It was the only tissue Jn which we were able to detect matrilysin, and it apparently synthesized different forms of stromelysin-1 and stromelysin-3 from those in normal liver and the hepatocellular carcinomas. This seems entirely possible, since different secreted proenzyme forms of stromelysin have been described in other tissue (14, (36) (37) (38) . Since matrix metalloproteinases are present in tissues mainly in their inactive pro-enzyme form, it is not surprising that our antibodies mainly recognize bands of the molecular mass of these proenzymes. In some of the gels more than one band was identified^ suggesting that the antibodies in our polyclonal antisera may recognize other forms of the enzymes as well, such as pre-pro-enzyrnes, degradation products with partly conserved structure or even enzyme/inhibitor complexes. On the other hand, bands of the size of the active forms were hardly detected, suggesting that the concentration of active enzyme in the tissue is very low. Apparently there is a certain redundancy in the expression of matrix metalloproteinases in the liver, in that almost the whole family of these enzymes can be detected. The precise regulation and cellular origin of these enzymes awaits further study.
Our results are surprising in that they show a much more abundant presence of matrix metalloproteinases in normal liver than hitherto described.
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